Intelligent Investor

Orthocell Limited (ASX: OCC) - Announcements

Current share price for OCC : $0.395 0.015 (3.95%)

ASX company news and announcements for Orthocell Limited (OCC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Orthocell Limited (OCC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Orthocell Limited (OCC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Orthocell Limited (OCC)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$83 Change of Director's Interest Notice-John Van Der Wielen 16 Apr 2024 8:56AM $0.385 $0.395 $0.380 risen by 2.60%
$83 Orthocell receives $3.05m R&D tax incentive refund 15 Apr 2024 9:03AM $0.380 $0.395 $0.380 risen by 3.95%
$83 Quarterly Activity Report & Appendix 4C 8 Apr 2024 9:03AM $0.415 $0.395 $0.380 fallen by 4.82%
$83 Part 1 Remplir US Market Authorisation Successfully Complete 25 Mar 2024 9:19AM $0.400 $0.395 $0.380 fallen by 1.25%
$83 Cleansing Notice 11 Mar 2024 6:06PM $0.400 $0.395 $0.380 fallen by 1.25%
$83 Application for quotation of securities - OCC 11 Mar 2024 6:05PM $0.400 $0.395 $0.380 fallen by 1.25%
$83 Application for quotation of securities - OCC 11 Mar 2024 6:04PM $0.400 $0.395 $0.380 fallen by 1.25%
$83 Cleansing Notice 28 Feb 2024 10:27AM $0.420 $0.395 $0.380 fallen by 5.95%
$83 Application for quotation of securities - OCC 28 Feb 2024 10:24AM $0.420 $0.395 $0.380 fallen by 5.95%
$83 Appendix 4D & Half-Year Financial Statements 23 Feb 2024 3:27PM $0.440 $0.395 $0.380 fallen by 10.23%
$83 Proposed issue of securities - OCC 22 Feb 2024 9:20AM $0.395 $0.395 $0.380 fallen by 0%
$83 Strategic Placement to Raise $3.5 million 22 Feb 2024 9:20AM $0.395 $0.395 $0.380 fallen by 0%
$83 Trading Halt 20 Feb 2024 9:43AM $0.395 $0.395 $0.380 fallen by 0%
$83 Remplir Expansion Continues with Singapore Application 13 Feb 2024 9:14AM $0.380 $0.395 $0.380 risen by 3.95%
$83 Notification of cessation of securities - OCC 6 Feb 2024 8:15AM $0.375 $0.395 $0.380 risen by 5.33%
$83 Quarterly Activity Report & Appendix 4C 29 Jan 2024 8:57AM $0.405 $0.395 $0.380 fallen by 2.47%
$83 Appendix 3Y - Kim Beazley 17 Jan 2024 2:14PM $0.410 $0.395 $0.380 fallen by 3.66%
$83 Notification regarding unquoted securities - OCC 17 Jan 2024 2:11PM $0.410 $0.395 $0.380 fallen by 3.66%
$83 Final Director's Interest Notice 16 Jan 2024 9:15AM $0.405 $0.395 $0.380 fallen by 2.47%
$83 Orthocell Board Changes 15 Jan 2024 4:50PM $0.405 $0.395 $0.380 fallen by 2.47%
$83 Initial Director's Interest Notice - Mr Kim Beazley 15 Jan 2024 11:05AM $0.400 $0.395 $0.380 fallen by 1.25%
$83 Proposed issue of securities - OCC 15 Jan 2024 9:18AM $0.400 $0.395 $0.380 fallen by 1.25%
$83 The Hon Kim Beazley AC Joins Orthocell Board 15 Jan 2024 9:13AM $0.400 $0.395 $0.380 fallen by 1.25%
$83 Final Director's Interest Notice 22 Dec 2023 9:11AM $0.410 $0.395 $0.380 fallen by 3.66%
$83 Orthocell Board Change 22 Dec 2023 8:55AM $0.410 $0.395 $0.380 fallen by 3.66%

1 - 25 of 545 results

Page 1 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.